Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma
作者： Steven P. Treon , Peter Maimonis , Deborah Bua , Gloria Young , Noopur Raje
关键词:
摘要: … MUC1 (sMUC1) levels are elevated in many MUC1 + cancers. We and others have shown that MUC1 is … healthy donors (HDs), and in peripheral blood (PB) plasma from 42 MM patients …
ashpublications.org
bloodjournal.org参考文章(49)
C Duperray, B Klein, BG Durie, X Zhang, M Jourdan, P Poncelet, F Favier, C Vincent, J Brochier, G Lenoir, Phenotypic analysis of human myeloma cell lines Blood. ,vol. 73, pp. 566- 572 ,(1989) , 10.1182/BLOOD.V73.2.566.566
Steven P. Treon, Joseph A. Mollick, Mitsuyoshi Urashima, Gerrard Teoh, Dharminder Chauhan, Atsushi Ogata, Noopur Raje, Joseph H.M. Hilgers, Lee Nadler, Andrew R. Belch, Linda M. Pilarski, Kenneth C. Anderson, Muc-1 Core Protein Is Expressed on Multiple Myeloma Cells and Is Induced by Dexamethasone Blood. ,vol. 93, pp. 1287- 1298 ,(1999) , 10.1182/BLOOD.V93.4.1287
Agnieszka J. Szczepek, P.L. Bergsagel, Linus Axelsson, Christopher B. Brown, Andrew R. Belch, Linda M. Pilarski, CD34 " Cells in the Blood of Patients With Multiple Myeloma Express CD19 and IgH mRNA and Have Patient-Specific IgH VDJ Gene Rearrangements Blood. ,vol. 89, pp. 1824- 1833 ,(1997) , 10.1182/BLOOD.V89.5.1824
PL Bergsagel, AM Smith, A Szczepek, MJ Mant, AR Belch, LM Pilarski, In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears in Blood 1995 Jun 1;85(11):3365] Blood. ,vol. 85, pp. 436- 447 ,(1995) , 10.1182/BLOOD.V85.2.436.BLOODJOURNAL852436
Agnieszka J. Szczepek, Karen Seeberger, Juanita Wizniak, Michael J. Mant, Andrew R. Belch, Linda M. Pilarski, A High Frequency of Circulating B Cells Share Clonotypic Ig Heavy-Chain VDJ Rearrangements With Autologous Bone Marrow Plasma Cells in Multiple Myeloma, as Measured by Single-Cell and In Situ Reverse Transcriptase-Polymerase Chain Reaction Blood. ,vol. 92, pp. 2844- 2855 ,(1998) , 10.1182/BLOOD.V92.8.2844
K Imai, T Takahashi, N Nakagawa, A Yachi, Y Makiguchi, Y Hinoda, H Kakiuchi, Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. Journal of Immunology. ,vol. 153, pp. 2102- 2109 ,(1994)
S. von Mensdorff-Pouilly, A.A. Verstraeten, P. Kenemans, F.G. M. Snijdewint, A. Kok, G.J. Van Kamp, M.A. Paul, P.J. Van Diest, S. Meijer, J. Hilgers, Survival in Early Breast Cancer Patients Is Favorably Influenced by a Natural Humoral Immune Response to Polymorphic Epithelial Mucin Journal of Clinical Oncology. ,vol. 18, pp. 574- 583 ,(2000) , 10.1200/JCO.2000.18.3.574
D W Chan, R A Beveridge, H Muss, H A Fritsche, G Hortobagyi, R Theriault, D Kiang, B J Kennedy, M Evelegh, Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease. Journal of Clinical Oncology. ,vol. 15, pp. 2322- 2328 ,(1997) , 10.1200/JCO.1997.15.6.2322
Donald W. Kufe, Stephen W. Rodrique, David S. Silberstein, Daniel F. Hayes, DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targets. Journal of Immunology. ,vol. 145, pp. 962- 970 ,(1990)
PA Moalli, S Pillay, D Weiner, R Leikin, ST Rosen, A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA Blood. ,vol. 79, pp. 213- 222 ,(1992) , 10.1182/BLOOD.V79.1.213.BLOODJOURNAL791213